BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
42 results:

  • 1. CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
    Söhngen C; Thomas DJ; Skowron MA; Bremmer F; Eckstein M; Stefanski A; Driessen MD; Wakileh GA; Stühler K; Altevogt P; Theodorescu D; Klapdor R; Schambach A; Nettersheim D
    FEBS J; 2023 Oct; 290(20):4864-4876. PubMed ID: 37254618
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
    Mohammadi A; Najafi S; Amini M; Baradaran B; Firouzamandi M
    Melanoma Res; 2023 Jun; 33(3):173-183. PubMed ID: 37053079
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype.
    Chen X; Adhikary G; Ma E; Newland JJ; Naselsky W; Xu W; Eckert RL
    Mol Carcinog; 2023 Feb; 62(2):236-248. PubMed ID: 36285644
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. p38 MAPK-dependent phosphorylation of transcription factor sox2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
    Pietrobono S; De Paolo R; Mangiameli D; Marranci A; Battisti I; Franchin C; Arrigoni G; Melisi D; Poliseno L; Stecca B
    J Biol Chem; 2022 Sep; 298(9):102353. PubMed ID: 35944584
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chelerythrine Chloride Inhibits Stemness of Melanoma cancer Stem-Like Cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction.
    Li H; He M; Zhao P; Liu P; Chen W; Xu X
    Comput Math Methods Med; 2022; 2022():4000733. PubMed ID: 35761835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
    Morimoto Y; Fushimi A; Yamashita N; Hagiwara M; Bhattacharya A; Cheng J; Frost TC; Ahmad R; Daimon T; Huang L; Hata T; Takahashi H; Yamamoto M; Suzuki Y; DeCaprio JA; Kufe D
    Oncogene; 2022 Jul; 41(27):3511-3523. PubMed ID: 35688945
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Veeragoni D; Deshpande S; Rachamalla HK; Ande A; Misra S; Mutheneni SR
    ACS Appl Bio Mater; 2022 May; 5(5):2324-2339. PubMed ID: 35426672
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
    Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
    Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Morusin enhances the antitumor activity of MAPK pathway inhibitors in BRAF-mutant melanoma by inhibiting the feedback activation of STAT3.
    Zhao K; Dai Q; Wu J; Wei Z; Duan Y; Chen B
    Eur J Cancer; 2022 Apr; 165():58-70. PubMed ID: 35219024
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers.
    Jiang W; Yang Y; Mercer-Smith AR; Valdivia A; Bago JR; Woodell AS; Buckley AA; Marand MH; Qian L; Anders CK; Hingtgen SD
    Sci Adv; 2021 Jun; 7(24):. PubMed ID: 34108203
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting non-canonical activation of GLI1 by the sox2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
    Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
    Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ST3GAL1 is a target of the sox2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
    Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
    Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.
    Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Biagioni A; Papucci L; Magnelli L; Mazzanti B; Stecca B; Calorini L
    J Mol Med (Berl); 2020 Oct; 98(10):1431-1446. PubMed ID: 32803272
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.
    Lazo de la Vega L; Bick N; Hu K; Rahrig SE; Silva CD; Matayoshi S; Picciarelli P; Wang X; Sugar A; Soong HK; Mian SI; Robinson DR; Chinnaiyan AM; Demirci H; Daniels AB; Worden F; Eberhart CG; Tomlins SA; Rao RC; Harms PW
    Mod Pathol; 2020 Nov; 33(11):2280-2294. PubMed ID: 32461624
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis.
    Samy ALPA; Bakthavachalam V; Vudutha M; Vinjamuri S; Chinnapaka S; Munirathinam G
    Toxicol Appl Pharmacol; 2020 Aug; 401():115071. PubMed ID: 32454055
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma.
    Yoganandarajah V; Patel J; van Schaijik B; Bockett N; Brasch HD; Paterson E; Sim D; Davis PF; Roth IM; Itinteang T; Tan ST
    Cells; 2020 Jan; 9(2):. PubMed ID: 32019273
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
    Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. sox2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma.
    Si X; Gao Z; Xu F; Zheng Y
    Mol Carcinog; 2020 Mar; 59(3):257-264. PubMed ID: 31883360
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Effects of TGF-β Signaling on cancer Cells and cancer Stem Cells in the Bone Microenvironment.
    Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
    Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
    Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.